{"id":"W4410952304","doi":"10.1016/s1470-2045(25)00287-6","title":"Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Jazz Pharmaceuticals","keywords":"Oxaliplatin; Medicine; Capecitabine; Regimen; Internal medicine; Tolerability; Chemotherapy; Gastroenterology; Dosing; Oncology; Adenocarcinoma; Adverse effect; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001655809,0.001362673,0.003112883,0.0004837003,0.0003029919,0.00115919,0.0008026505,0.001054509,0.002888905],"category_scores_gemma":[0.001177756,0.0006814081,0.002346521,0.0005543993,0.0007359312,0.00101945,0.0003336682,0.002872069,0.000652768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009210615,"about_ca_system_score_gemma":0.0009534614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001599428,"about_ca_topic_score_gemma":0.00604533,"domain_scores_codex":[0.9995709,0.0002222368,0.00002169038,0.00006662902,0.0000382009,0.00008023845],"domain_scores_gemma":[0.9993974,0.0001277617,0.0001625455,0.00005081647,0.00003567551,0.0002259519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8922676,0.0141988,0.004135979,0.001740844,0.004135097,0.00009852435,0.00017607,0.001812822,0.009438254,0.0001283579,0.00219432,0.06967343],"study_design_scores_gemma":[0.8242712,0.1521995,0.01721502,0.00008487234,0.002499519,0.0001359496,0.00008446425,0.0008150678,0.0007835426,0.0001613029,0.001707875,0.00004168201],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880052,0.007970619,0.00029375,0.0005291207,0.000259607,0.0007457594,0.0009243804,0.00006044716,0.001211132],"genre_scores_gemma":[0.9853897,0.007186981,0.001129712,0.0009956533,0.0002339971,0.000682368,0.001753683,0.00003765627,0.002590299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003112883,"threshold_uncertainty_score":0.009664416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04556820725942549,"score_gpt":0.3980022265406252,"score_spread":0.3524340192811997,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}